newsfilter
← Latest News
GlobeNewswire·

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacyPhase 2 data featured in an oral presentation